Study: Cannabis Exposure Not Associated with Increased Psychosis Risk Among High-Risk Youth

The use of cannabis doesn’t raise one’s risk of psychosis or other adverse health outcomes, even among adolescents who are at high risk for the disorder, according to longitudinal data published in the journal Psychiatry Research.

A team of researchers affiliated with Hofstra University in New York and with Stanford University in California assessed the relationship between cannabis use and health outcomes in a cohort of adolescents at clinical high risk for psychosis. Study participants were tracked for two years. 

Investigators reported that those subjects who consumed cannabis were no more likely than non-users to become psychotic. 

Authors concluded: [C]ontinuous cannabis use over 2-years of follow-up was not associated with an increased psychosis transition rate, and did not worsen clinical symptoms, functioning levels, or overall neurocognition …  indicating that CHR [clinical high risk] youngsters are not negatively impacted by cannabis. … These findings should be confirmed in future clinical trials with larger samples of cannabis using individuals.”

The findings are similar to those published in April in the journal Psychiatry and Clinical Neurosciences. That study also failed to identify cannabis use as a risk factor for psychosis in clinically at-risk subjects. The study’s authors concluded: “Our primary hypothesis was that cannabis use in CHR [clinically high risk] subjects would be associated with an increased rate of later transition to psychosis. However, there was no significant association with any measure of cannabis use. … These findings are not consistent with epidemiological data linking cannabis use to an increased risk of developing psychosis.” 

Keep reading

Delaware’s Beach Towns, Known For Boozy Parties, Are Banning Marijuana Businesses

Three of Delaware’s six most prominent beach towns have now voted to ban cannabis dispensaries, while the other three are in discussions to do the same. All are located in Sussex County, the state’s Republican stronghold.

The first town, Dewey Beach, passed its ordinance in June. On August 18, Rehoboth Beach and Bethany Beach followed suit. Fenwick Island began drafting an ordinance in July. South Bethany is expected to be reviewing one of its own in September or October. Lewes is in similar discussions.

The slightly inland town of Ocean View, also part of Sussex County, introduced a proposed ordinance in July. Its town council does not meet in August and so the ban will not be voted on until at least September.

“It’s almost laughable,’’ Mark Jacobs, a member of the state’s Marijuana Control Act Oversight Committee, told WHYY. “I mean, Dewey Beach, which encourages excessive drinking, whose clubs are fined yearly for violating the state’s alcohol laws. It’s hypocritical that a town that has the well-earned reputation of being a party town is first to jump on the old, debunked reefer madness attitude that it’s somehow perfectly acceptable to get sloshed drunk, but it’s not acceptable to get a little stoned.”

In April, Delaware passed legislation that legalized cannabis for adult use and then regulated its commercial sale. But it also permits jurisdictions to ban cannabis businesses at the local level. Only jurisdictions within Sussex County, the southernmost of Delaware’s three counties, have so far taken steps to do so, with legislators warning that dispensaries would attract “unsavory” people and residents stating that cannabis use is incompatible with a beach being family-friendly.

Keep reading

States That Legalized Medical Marijuana Saw Nearly 20 Percent Drop In Foster Care Cases For Parental Drug Misuse, Study Finds

States that legalized medical marijuana saw a nearly 20 percent drop in the number of children entering foster care due to parental drug misuse after three years of the reform, a new study found. Legalizing for adult use, meanwhile, was not associated with any statistically significant change in foster care entries.

Researchers at Georgia College and State University set out to learn whether legalization would “lessen stigma, permit proper use, and reduce the chance that a child will be removed” or, conversely, if foster care cases would increase due to expanded access to legal cannabis.

The study looked at national data involving 3.4 million foster care cases from 2007 to 2019. Using difference-in-differences analyses, researchers examined rate changes in foster case placements related to drug misuse, comparing states that enacted legalization to those that maintained prohibition. They controlled for factors such as state unemployment rate and per capita income.

“Our estimates suggest that when states permitted recreational marijuana use, there was no corresponding change in the number of foster care entries related to parental or teenage drug abuse relative to control states,” the study says.

But for states that legalize medical cannabis, there was a discernible shift. In the first two years of implementation, states saw an average eight percent to 10 percent decrease in foster care cases connected to drug misuse. By the third year, cases dropped 18 percent, which amounted to “approximately 700 fewer entries to foster care [that] were related to parental drug abuse when a state legalized medical marijuana.”

That’s an especially important finding given that 90 percent of foster case entries due to drug misuse happen in states where medical cannabis is legal, says the study, which is pending peer review. Drug misuse is the second most common reason that a child is placed into foster care.

The study also compared states that have restrictive versus comprehensive medical cannabis programs, but researchers said they are “hesitant to draw conclusions” about the differences because of conflicting data using two analytic models.

For limited medical marijuana states, there was a “sizable decrease” in foster care drug misuse cases in the third and fourth year after implementation based on one difference-in-difference model, but that effect was less pronounced in the other model.

States with less restrictive medical cannabis legalization laws, in contrast, showed a “statistically and economically significant decrease in the number of entries” in one model, but data from the other model was less clear.

“Our findings suggest that states which legalized medical marijuana experienced a decrease in parental drug abuse-related entries into foster care in the initial years following the legalization compared to states that did not legalize medical marijuana,” the study says. “Estimates exploiting variation in state-level limitations on medical marijuana are mixed.”

Keep reading

DeSantis Doubles Down On Opposition To Marijuana Legalization, Claiming Colorado’s Illicit Market Is ‘Bigger And More Lucrative’ After Reform

Florida Gov. Ron DeSantis (R), a 2024 Republican presidential candidate, has reaffirmed that he would not legalize marijuana if elected to the White House—arguing contrary to evidence that the reform has actually increased the size of the illicit market in Colorado.

During a campaign event in Iowa on Saturday, an attendee told DeSantis that she knows people whose children developed “cannabis-induced psychosis” and asked about whether he would move to legalize or reschedule cannabis under federal law if he became president. In response, the GOP contender made clear that he “would not legalize,” echoing anti-marijuana arguments he previously made in June.

“I think what’s happened is this stuff is very potent now. I think when young people get it, I think it’s a real, real problem, and I think it’s a lot different than stuff that people were using 30, 40 years ago,” DeSantis said. “I think when kids get on that, I think it causes a lot of problems and then, of course, you know, they can throw fentanyl in any of this stuff now.”

The candidate then pivoted to a broader discussion about the harms of substance misuse, stating that there’s an “open air market” for illicit drugs in San Francisco, and that society has “totally decayed” under policies that “really help these folks use drugs.”

DeSantis did acknowledge that Floridians have access to medical cannabis under a constitutional amendment that voters approved, saying that “we abide by that” but noting that “states have handled cannabis differently” and he would not “take action now to make it even more available.”

Florida voters may have the choice to expand access regardless of the governor’s position, as the state Supreme Court is currently considering whether a marijuana legalization initiative will appear on the state’s 2024 ballot.

“I would not do that,” DeSantis said on Saturday. “And the places that legalized it like Colorado and California, you know, the argument was—and honestly it wasn’t a crazy argument—’Look, we know people are going to use marijuana. It is a drug. If you legalize it, then you can tax it, regulate it, and it’s going to end up being safer for people.’”

“But what’s happened in Colorado, the black market for marijuana is bigger and more lucrative than it was before they did the legalization,” the governor said. “So the legalization I don’t think has worked.”

DeSantis didn’t provide data or cite any sourcing to support that argument. But private and government analyses have suggested that Colorado has in fact significantly reduced the influence of the illicit market in the decade since enacting legalization.

Keep reading

Missouri Foster Parents May Now Legally Possess And Grow Marijuana In Their Homes Under New Emergency Rule

Foster parents in Missouri can now legally possess and grow marijuana in their homes under an emergency rule filed last week by the state Department of Social Services. Consuming cannabis in a manner that emits smoke or vapor, however, is still not allowed inside the house.

Missouri voters in November 2022 passed a ballot initiative, Amendment 3, to legalize and regulate marijuana for adults 21 and older, allowing the purchase and possession of up to three ounces of cannabis and, after registering, the growth of up to six mature plants for personal use. But until Monday, the foster parents of roughly 14,000 children in the state were prohibited from exercising those rights.

The changes to the state rule addressing “physical and environmental standards” for foster care in Missouri were adopted on an emergency basis because the existing policy was in conflict with the voter-approved constitutional amendment, according to a statement attached to the rule’s text.

“Rule 13 CSR 35-60.040 presently provides that foster parents shall not use or possess marijuana or marijuana-infused products,” it says. “A regulation that conflicts with the Missouri Constitution is invalid.”

As an emergency rule, the change is set to expire February 23 of next year.

Keep reading

Cannabis Doesn’t Increase Heart Attack Risk

Middle-aged adults with a history of cannabis use over the previous year did not have a higher risk of suffering a heart attack, according to the results of a recent study by researchers at the University of California in San Diego.

The new study, “Associations Between Monthly Cannabis Use and Myocardial Infarction in Middle-Aged Adults: NHANES 2009 to 2018,” was published on August 7 in the peer-reviewed American Journal of Cardiology, found that a history of cannabis use over the previous year was not associated with an elevated risk of myocardial infarction (MI) among a nationally representative study of nearly 10,000 adults aged 35 to 59. Additionally, study participants who reported using cannabis in the month before experiencing an MI, also commonly known as a heart attack, showed a lower risk compared to participants who had not used cannabis recently.

“In a representative sample of middle-aged US adults, a history of monthly cannabis use for more than a year before a myocardial infarction was not linked to a subsequent physician-diagnosed MI, after accounting for cardiovascular risk factors,” the authors of the study wrote. “However, when considering recent use, the odds were three times greater if no use was reported in the past month.”

Keep reading

Some Drug Warriors Just Won’t Concede Defeat

There’s a fine art to refusing to learn lessons that are right in front of your eyes. A recent newspaper column demonstrated mastery of that art, managing to simultaneously acknowledge the failures of America’s drug policy while calling for more of the same. The author acknowledged that mandatory minimums do no good and then suggested that the right course of action is to prosecute drug dealers harder. But harder drug law enforcement gets you harder drug problems.

“News coverage of a Mesa police officer losing consciousness in his patrol car from an overdose certainly highlights, if sensationally, the crisis that is opioids, in particular fentanyl,” wrote Abe Kwok, editorial page planner for the Arizona Republic. “As critics such as the libertarian think tank Cato Institute note, harsh mandatory sentencing laws do nothing to blunt narcotic drugs’ effects.”

He added that “the institute pointed to a 1,500% spike in methamphetamine deaths in the United States between 2006 and 2021, following voter-approved Proposition 301 in Arizona that imposed mandatory minimum prison sentences for possessing, transferring, selling, distributing or manufacturing meth.”

Kwok also acknowledged that other restrictive policies, especially limitations on opioid prescriptions “did little to slow deaths from overdoses but created their own set of problems, such as blocking access to relief for chronic pain sufferers.” This is an important point championed by the late Siobhan Reynolds and the Pain Relief Network over a decade ago and still a matter of serious concern for many Americans. Last year, the Centers for Disease Control and Prevention finally acknowledged that opioid guidelines are being interpreted inflexibly. The CDC emphasized that “some policies purportedly drawn from the 2016 CDC Opioid Prescribing Guideline have been notably inconsistent with it and have gone well beyond its clinical recommendations” resulting in “untreated and undertreated pain.”

So far, so good for Kwok. Except, he refuses to take these arguments to their logical conclusion.

Keep reading

Fleeing Bronx drug suspect dies when cop knocks him off scooter with cooler; sergeant suspended by NYPD

A scooter-riding suspect fleeing a Bronx buy-and-bust drug sting was killed when an NYPD sergeant smacked him with a cooler grabbed from a local family’s outing, sending the victim tumbling to his death, an eyewitness and police sources said Thursday.

NYPD Sgt. Erik Duran, an NYPD Bronx narcotics veteran who joined the force in 2010, was suspended without pay just hours after the lethal encounter, police said.

An eyewitness, a 25-year local resident, was with relatives when the clash began on Aqueduct Ave. near W. 190th St. about 5:30 p.m. Wednesday in Kingsbridge Heights.

The 30-year-old suspect, Eric Duprey, “was on the bike, moving north when the cops started chasing him,” said the 42-year-old witness, speaking on the condition of anonymity. “Then he took a U-turn and was riding on the sidewalk… The cop then took my cooler, which was filled with soda cans, water bottles, and hit him.”

The victim’s wife Orlyanis Velez said police were providing her with no details of the deadly encounter.

Keep reading

Former Trump Drug Czar Says Top Federal Officials Stopped FDA From Scheduling Kratom Amid Concern About Agency’s ‘Bias’

As the U.S. Food and Drug Administration (FDA) under the Trump administration prepared to propose federal restrictions on kratom, a number of top officials intervened, criticizing the agency’s “bias” and stopping it “on the spot” from moving ahead with scheduling, a former White House drug czar said in a new interview.

“They did not give—did not have—the entire facts. They didn’t have the science,” said Jim Carroll, who served as director of the Office of National Drug Control Policy, or drug czar, under President Donald Trump from 2018 to 2021. “FDA did not paint the entire picture. Maybe they didn’t have the entire picture, but everyone else did.”

Carroll, who now works as a private lawyer and consultant, made the comments during a discussion with Mac Haddow, senior fellow at the American Kratom Association (AKA), during the National Conference of State Legislatures summit in Indianapolis earlier this month.

The former White House official said that as the Trump administration was considering whether to schedule kratom under the Controlled Substances Act, around 2018, FDA gave a presentation to his office that misstated the drug’s risk profile and potential benefits.

The agency was “talking about kratom being an opioid. We know that’s wrong, it’s flat-out wrong,” Carroll said. “They said that it’s highly addictive. Johns Hopkins [and] other medical, independent researchers have said it’s no more addictive than a cup of coffee in the morning, which I had before this interview.”

Keep reading

U.S. Citizens Were 89% of Convicted Fentanyl Traffickers in 2022

Fentanyl overdoses tragically caused tens of thousands of preventable deaths last year. Many politicians who want to end U.S. asylum law claim that immigrants crossing the border illegally are responsible. An NPR‐​Ipsos poll found that 39 percent of Americans and 60 percent of Republicans believe, “Most of the fentanyl entering the U.S. is smuggled in by unauthorized migrants crossing the border illegally.” A more accurate summary is that fentanyl is overwhelmingly smuggled by U.S. citizens, almost entirely for U.S. citizen consumers.

Here are the facts:

  • Fentanyl smuggling is ultimately funded by U.S. consumers who pay for illicit opioids: nearly 99 percent of whom are U.S. citizens.
  • In 2022, U.S. citizens were 89 percent of convicted fentanyl drug traffickers—12 times greater than convictions of illegal immigrants for the same offense.
  • In 2023, 93 percent of fentanyl seizures occurred at legal crossing points or interior vehicle checkpoints, not on illegal migration routes, so U.S. citizens (who are subject to less scrutiny) when crossing legally are the best smugglers.
  • The location of smuggling makes sense because hard drugs at ports of entry are at least 96 percent less likely to be stopped than people crossing illegally between them.
  • At most, just 0.009 percent of the people arrested by Border Patrol for crossing illegally possessed any fentanyl whatsoever.
  • Each individual busted for fentanyl by Border Patrol possessed, on average, half as much fentanyl as each person busted at ports of entry in 2023 (10 versus 20 pounds).
  • The government exacerbated the problem by banning most legal cross‐​border traffic in 2020 and 2021, accelerating a switch to fentanyl (the easiest‐​to‐​conceal drug).
  • During the travel restrictions, fentanyl seizures at ports quadrupled from fiscal year 2019 to 2021. Fentanyl went from a third of combined heroin and fentanyl seizures to over 90 percent.
  • Annual deaths from fentanyl nearly doubled from 2019 to 2021 after the government banned most travel (and asylum).

It is monstrous that tens of thousands of people are dying unnecessarily every year from fentanyl. But banning asylum and limiting travel backfired. Reducing deaths requires figuring out the cause, not jumping to blame a group that is not responsible. Instead of attacking immigrants, policymakers should focus on effective solutions that help people at risk of a fentanyl overdose.

Keep reading